Bridgefront Capital’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.22M Buy
132,703
+60,014
+83% +$670K 0.32% 88
2026
Q1
$787K Buy
+72,689
New +$622K 0.2% 170
2025
Q4
Sell
-12,930
Closed -$67K 732
2025
Q3
$67K Sell
12,930
-2,279
-15% -$13.1K 0.02% 561
2025
Q2
$90.2K Buy
+15,209
New +$91.6K 0.02% 575
2023
Q3
Sell
-30,023
Closed -$359K 567
2023
Q2
$359K Buy
30,023
+13,230
+79% +$149K 0.19% 201
2023
Q1
$196K Buy
+16,793
New +$245K 0.12% 346

Other funds holding PTEN

Bridgefront Capital's PTEN Position: Q2 2026 in Review

Bridgefront Capital increased its Patterson-UTI (PTEN) stake by 83% in Q2 2026, buying an estimated $670K and bringing the position to 132,703 shares worth $1.22M. The position accounts for 0.32% of the portfolio, ranked #88.

Bridgefront Capital first reported a position in PTEN in Q1 2023 and has held it in 6 quarters since. 437 funds tracked by Wall St. Rank hold PTEN as of Q2 2026.

  • Bridgefront Capital held 132,703 shares of Patterson-UTI worth $1.22M as of Q2 2026.
  • Bridgefront Capital bought 60,014 Patterson-UTI shares in Q2 2026, an estimated $670K.
  • Patterson-UTI made up 0.32% of Bridgefront Capital's portfolio in Q2 2026, its #88 holding.
  • Bridgefront Capital first reported a position in Patterson-UTI in Q1 2023 and has held it in 6 quarters since.
  • 437 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2026.

Based on Bridgefront Capital's 13F filing for Q2 2026, filed 14 Aug 2026.